X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (195865) 195865
Publication (17782) 17782
Newsletter (9282) 9282
Newspaper Article (7382) 7382
Book Review (1462) 1462
Government Document (723) 723
Book Chapter (701) 701
Magazine Article (395) 395
Conference Proceeding (325) 325
Dissertation (237) 237
Book / eBook (156) 156
Web Resource (95) 95
Trade Publication Article (80) 80
Streaming Video (47) 47
Data Set (29) 29
Reference (26) 26
Transcript (19) 19
Paper (14) 14
Journal / eJournal (5) 5
Presentation (5) 5
Report (2) 2
Pamphlet (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (137564) 137564
breast cancer (100564) 100564
female (97602) 97602
index medicus (93374) 93374
oncology (85795) 85795
cancer (67370) 67370
breast-cancer (49290) 49290
middle aged (46414) 46414
breast neoplasms - pathology (40897) 40897
aged (36286) 36286
metastasis (36103) 36103
adult (35772) 35772
animals (35315) 35315
research (35204) 35204
tumors (32849) 32849
expression (32483) 32483
male (29688) 29688
prognosis (27939) 27939
cell line, tumor (27334) 27334
carcinoma (24597) 24597
apoptosis (23635) 23635
gene expression (23271) 23271
care and treatment (21887) 21887
mice (21537) 21537
cell biology (21447) 21447
chemotherapy (21426) 21426
immunohistochemistry (21408) 21408
breast neoplasms - metabolism (20962) 20962
proteins (20813) 20813
genetic aspects (20306) 20306
breast neoplasms - genetics (20074) 20074
health aspects (19719) 19719
analysis (19167) 19167
pathology (17924) 17924
oncology, experimental (15840) 15840
cancer therapies (15563) 15563
biochemistry & molecular biology (15361) 15361
aged, 80 and over (15301) 15301
medicine & public health (14916) 14916
development and progression (14725) 14725
gene expression regulation, neoplastic (14380) 14380
survival (14167) 14167
breast neoplasms - drug therapy (13923) 13923
breast (13895) 13895
surgery (13784) 13784
research article (13472) 13472
medicine (13439) 13439
cells (13301) 13301
risk factors (12637) 12637
medical prognosis (12050) 12050
growth (11992) 11992
studies (11961) 11961
signal transduction (11583) 11583
article (11484) 11484
kinases (11462) 11462
cell proliferation (11404) 11404
diagnosis (11226) 11226
genes (10542) 10542
neoplasm staging (10535) 10535
mutation (10487) 10487
cell cycle (10322) 10322
multidisciplinary sciences (10217) 10217
metastases (10110) 10110
tumor cells, cultured (9847) 9847
patients (9709) 9709
medical research (9681) 9681
therapy (9320) 9320
proliferation (9218) 9218
medicine, research & experimental (9198) 9198
angiogenesis (8999) 8999
physiological aspects (8595) 8595
gene-expression (8575) 8575
lung cancer (8474) 8474
cancer research (8432) 8432
activation (8370) 8370
cell growth (8327) 8327
biomarkers (8253) 8253
women (8034) 8034
biology (7943) 7943
pharmacology & pharmacy (7940) 7940
science (7826) 7826
estrogen (7783) 7783
risk (7770) 7770
neoplasm invasiveness (7739) 7739
treatment outcome (7724) 7724
antineoplastic agents - pharmacology (7660) 7660
phosphorylation (7581) 7581
genetics & heredity (7570) 7570
neoplasm metastasis (7526) 7526
gene (7289) 7289
retrospective studies (7282) 7282
prostate-cancer (7219) 7219
invasion (7165) 7165
breast neoplasms - diagnosis (7026) 7026
biopsy (6908) 6908
in-vitro (6884) 6884
protein (6854) 6854
stem cells (6842) 6842
ovarian cancer (6793) 6793
lymphatic metastasis (6776) 6776
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (43) 43
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (14) 14
Online Resources - Online (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
St. Michael's Hospital - Stacks (3) 3
Women's College Hospital - Stacks (3) 3
Markham Stouffville Hospital - Stacks (2) 2
Media Commons - Microtexts (2) 2
Mt Sinai Hospital - Pathology (2) 2
Credit Valley Hospital - Special Collections (1) 1
Gerstein Science - Theses (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Women's College Hospital - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (211247) 211247
Japanese (1022) 1022
German (937) 937
French (797) 797
Chinese (514) 514
Russian (245) 245
Spanish (218) 218
Polish (134) 134
Korean (132) 132
Italian (119) 119
Portuguese (77) 77
Czech (42) 42
Hungarian (28) 28
Turkish (20) 20
Dutch (16) 16
Arabic (14) 14
Serbian (14) 14
Romanian (12) 12
Latvian (10) 10
Persian (10) 10
Bulgarian (8) 8
Croatian (8) 8
Danish (8) 8
Norwegian (8) 8
Hebrew (5) 5
Slovenian (5) 5
Slovak (4) 4
Bosnian (3) 3
Finnish (3) 3
Welsh (3) 3
Swedish (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Catalan (1) 1
Estonian (1) 1
Icelandic (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, p. e0136023
Background Immunotherapy can become a crucial therapeutic option to improve prognosis for lung cancer patients. First clinical trials with therapies targeting... 
CELL LUNG-CANCER | TUMOR-INFILTRATING LYMPHOCYTES | INTERLEUKIN-2 | GEFITINIB | IMPACT | MULTIDISCIPLINARY SCIENCES | ANTIBODY | B7-H1 | T-CELLS | CHEMOTHERAPY | LIGAND 1 EXPRESSION | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Immunoenzyme Techniques | Adenocarcinoma - metabolism | Carcinoma, Squamous Cell - mortality | Neoplasm Grading | Biomarkers, Tumor - metabolism | Female | Retrospective Studies | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Large Cell - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Carcinoma, Squamous Cell - therapy | Programmed Cell Death 1 Receptor - metabolism | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | B7-H1 Antigen - metabolism | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Care and treatment | Physiological aspects | Genetic aspects | Research | Lung cancer, Non-small cell | Apoptosis | Immunohistochemistry | Thoracic surgery | PD-1 protein | Lung cancer | Clinical trials | Oncology | Cancer therapies | Lymph nodes | Subgroups | Proteins | Rank tests | Regression models | Bcl-x protein | Lymphocytes | Immunotherapy | Medical research | Immunoglobulins | Squamous cell carcinoma | Cell survival | Cytokines | Hematology | Tumor cells | Non-small cell lung carcinoma | Breast cancer | Regression analysis | Patients | Medicine | Pathology | Chemotherapy | Hospitals | Cell death | Medical prognosis | PD-L1 protein | Ligands | Diagnostic systems | Solid tumors | Cancer | Tumors
Journal Article
Journal Article
Journal of mammary gland biology and neoplasia, ISSN 0183-3021, 1996
Journal
CANCER RESEARCH, ISSN 0008-5472, 07/2017, Volume 77, Issue 13, pp. 3540 - 3550
Antibody targeting of the immune checkpoint receptor PD1 produces therapeutic activity in a variety of solid tumors, but most patients exhibit partial or... 
BREAST-CANCER | BIOMARKERS | ANTI-PD-1 THERAPY | PEMBROLIZUMAB | ONCOLOGY | CLINICAL ONCOLOGY/COLLEGE | RECOMMENDATIONS | SENSITIVITY | MECHANISMS | TUMORS | AMERICAN SOCIETY | Gene Expression - drug effects | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Squamous Cell Carcinoma of Head and Neck | Melanoma - genetics | Gene Expression - immunology | Aged, 80 and over | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Non-Small-Cell Lung - genetics | Head and Neck Neoplasms - drug therapy | Gene Expression Profiling - methods | Melanoma - pathology | Head and Neck Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - immunology | Lung Neoplasms - immunology | Carcinoma, Squamous Cell - drug therapy | Melanoma - immunology | Melanoma - drug therapy | Nivolumab | Head and Neck Neoplasms - genetics | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Programmed Cell Death 1 Receptor - immunology | Programmed Cell Death 1 Receptor - genetics | PD-1 protein | CD8 antigen | Antibodies | Activation | Lymphocytes T | Killer cells | Cell activation | Lymphocytes | Natural killer cells | Signatures | Immune system | Squamous cell carcinoma | Head | Immune response | Small cell lung carcinoma | Tumor-infiltrating lymphocytes | Melanoma | Lung carcinoma | Gene expression | Ribonucleic acid--RNA | Patients | CD4 antigen | Immune checkpoint | Reproducibility | PD-L1 protein | Biomarkers | Head and neck cancer | Interferon | Solid tumors | Cancer | Tumors
Journal Article
Neurology, ISSN 0028-3878, 02/2020, Volume 94, Issue 5, pp. e521 - e528
OBJECTIVEThe primary objective was to determine the sensitivity and specificity of epithelial cell adhesion molecule (EpCAM) immunoflow cytometry circulating... 
FLOW-CYTOMETRY | DNA ANALYSIS | TECHNOLOGY | CLINICAL NEUROLOGY | CEREBROSPINAL-FLUID CYTOLOGY | DIAGNOSTIC-ACCURACY | Small Cell Lung Carcinoma - cerebrospinal fluid | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | ErbB Receptors - genetics | Ovarian Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - cerebrospinal fluid | Lung Neoplasms - pathology | Male | Carcinoma, Non-Small-Cell Lung - diagnosis | Meningeal Carcinomatosis - secondary | Carcinoma - cerebrospinal fluid | Meningeal Carcinomatosis - genetics | Epithelial Cell Adhesion Molecule | Small Cell Lung Carcinoma - secondary | Gastrointestinal Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - secondary | Flow Cytometry | Sensitivity and Specificity | Carcinoma, Lobular - cerebrospinal fluid | Aged, 80 and over | Meningeal Carcinomatosis - cerebrospinal fluid | Adult | Female | Carcinoma, Ductal, Breast - cerebrospinal fluid | Carcinoma, Transitional Cell - cerebrospinal fluid | Carcinoma, Ductal, Breast - secondary | Carcinoma - secondary | Carcinoma, Lobular - secondary | Lung Neoplasms - genetics | Meningeal Carcinomatosis - diagnosis | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Transitional Cell - diagnosis | Carcinoma - diagnosis | Carcinoma, Lobular - diagnosis | Carcinoma, Ductal, Breast - diagnosis | Magnetic Resonance Imaging | Breast Neoplasms - pathology | Neoplastic Cells, Circulating | Small Cell Lung Carcinoma - diagnosis | Aged
Journal Article
Journal Article
BioImpacts, ISSN 2228-5660, 12/2018, Volume 8, Issue Suppl 1, pp. S1 - S129
Journal Article
Oncogene, ISSN 0950-9232, 01/2012, Volume 31, Issue 2, pp. 149 - 160
MicroRNAs are often associated with the pathogenesis of many cancers, including head and neck squamous cell carcinoma (HNSCC). In particular, microRNA-21... 
nanog | Stat-3 | miR-21 | hyaluronan | CD44 | head & neck cancer | ACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSCRIPTION | RHO-KINASE | TUMOR-CELLS | BREAST | CELL BIOLOGY | ONCOLOGY | GENETICS & HEREDITY | GENE-EXPRESSION | CANCER STATISTICS | NF-KAPPA-B | PROGRESSION | Promoter Regions, Genetic | Nanog Homeobox Protein | Signal Transduction | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Homeodomain Proteins - metabolism | Humans | Drug Resistance, Neoplasm | MicroRNAs - metabolism | Head and Neck Neoplasms - metabolism | Head and Neck Neoplasms - pathology | Cell Nucleus - metabolism | Hyaluronic Acid - metabolism | Hyaluronan Receptors - metabolism | Cell Line, Tumor | Head and Neck Neoplasms - genetics | MicroRNAs - genetics | STAT3 Transcription Factor - metabolism | Physiological aspects | Head and neck cancer | Genetic aspects | MicroRNA | Research | Stem cells | Signal transduction | Chemotherapy | Head & neck cancer | Gene expression | Drug resistance | Tyrosine | Chromatin | IAP protein | Cell survival | Immunoprecipitation | Tumor cells | Chemoresistance | Stat3 protein | siRNA | Nuclear transport | Promoters | CD44 antigen | Transcription activation | Tumor suppressor genes | miRNA | Apoptosis | Tumors | squamous cell carcinoma | Nanog
Journal Article
Journal Article